Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Svetlana Lucas

Chief Business Officer at Scribe Therapeutics, Inc. (SCTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$19K
Total bought / sold$45K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jul 27SEC SCTXScribe Therapeutics, Inc. Buy 3,000new position $15.00 $45K +41.1%
  • Buy

    Chief Business Officer Svetlana Lucas bought $45K of SCTX at $15.00 — first open-market purchase in our records; opens a new position.